NLRP3 and rheumatoid arthritis: Both CY-09 and tranilast (TR) (118–120) bind directly to the ATP-binding motif of the NACHT domain of NLRP3 to inhibit ATPase activity and thus prevent the assembly of NLRP3 inflammasome, which may be promising in the management of rheumatoid arthritis.